XML 18 R16.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Income Taxes
9 Months Ended
Dec. 31, 2019
Income Tax Disclosure [Abstract]  
Income Taxes

Note 9. Income Taxes

A reconciliation of the income tax expense at the statutory rate to the provision for income taxes is as follows:

 

 

 

Quarter ended

 

 

Nine months ended

 

 

 

December 31,

 

 

December 31,

 

 

 

2019

 

 

2018

 

 

2019

 

 

2018

 

Income tax expense at statutory rate

 

$

 

 

$

 

 

$

 

 

$

 

Foreign tax rate differential

 

 

(1,436

)

 

 

(1,328

)

 

 

(3,035

)

 

 

(3,812

)

Increase in valuation allowance against deferred

   tax assets

 

 

1,450

 

 

 

1,339

 

 

 

3,076

 

 

 

3,845

 

Provision for income tax

 

$

14

 

 

$

11

 

 

$

41

 

 

$

33

 

 

Significant components of deferred tax are as follows:

 

 

December 31,

2019

 

 

March 31,

2019

 

Provisions and reserves

 

$

1,484

 

 

$

1,442

 

Fixed asset basis difference

 

 

44

 

 

 

34

 

Operating lease liability

 

 

3,994

 

 

 

 

Net operating loss carry forwards

 

 

20,313

 

 

 

17,330

 

Gross deferred tax assets

 

$

25,835

 

 

$

18,806

 

Operating lease right-of-use assets

 

$

(3,994

)

 

$

 

Net deferred tax asset

 

$

21,841

 

 

$

18,806

 

Valuation allowance

 

 

(21,277

)

 

 

(18,201

)

Total

 

$

564

 

 

$

605

 

 

The balance sheet classification of deferred tax is as follows:

 

 

 

December 31,

2019

 

 

March 31,

2019

 

Net noncurrent deferred tax assets

 

$

564

 

 

$

605

 

Total

 

$

564

 

 

$

605

 

 

In connection with the sale and leaseback transaction of the Biocampus facility that was completed in March 2018, the Company has agreed to transfer tax allowances related to certain other property, plant and equipment to the purchaser of the facility. An election to effect the transfer of these allowances to the purchaser has been made, but due to uncertainty regarding whether the election will be effective, the tax effect of the transfer of the allowances has not been recorded in the financial statements as at December 31, 2019. If the transfer of the allowances was regarded as being effective at December 31, 2019, the financial statements would reflect an additional deferred tax expense of $1,004 and an equivalent deferred tax liability. The Company will continue to monitor the position regarding the effectiveness of the election to transfer the allowances in order to determine whether the deferred tax liability should be recorded.